PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

target, page-6

  1. faimac
    9 Posts.
    clock Created with Sketch.
    28/02/08
    10:01
    Post #: 3405539
    Elan, Biogen slide on Tysabri warning
    By Val Brickates Kennedy, MarketWatch
    Last update: 2:46 p.m. EST Feb. 27, 2008
    BOSTON (MarketWatch) - Shares of partners Elan Corp. and Biogen Idec were trending downward Wednesday afternoon, following news that the Food and Drug Administration has issued a new safety warning about its multiple sclerosis drug Tysabri.



    sigh
    ANP Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
8.0¢ 8.0¢ 7.5¢ $76.58K 983.1K

Buyers (Bids)

No. Vol. Price($)
1 12425 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 167897 3
View Market Depth
Last trade - 16.10pm 02/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.